The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

LUMO Insider Trading (Lumos Pharma)

Insider Ownership Percentage: 21.20%
Insider Buying (Last 12 Months): $1,949,462.70
Insider Selling (Last 12 Months): $18,420.48

Lumos Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Lumos Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lumos Pharma Share Price & Price History

Current Price: $7.69
Price Change: Price Increase of +0.26 (3.50%)
As of 05/17/2022 01:35 PM ET

This chart shows the closing price history over time for LUMO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Investors Look to Capitalize on the Budding Green Revolution
Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors.
Discover this company's HUGE lithium potential

Lumos Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/5/2022John C MckewInsiderSell2,214$8.32$18,420.4829,271View SEC Filing Icon  
9/7/2021Kevin M. LalandeDirectorBuy10,000$11.11$111,100.00View SEC Filing Icon  
9/3/2021Kevin M. LalandeDirectorBuy8,100$11.35$91,935.00View SEC Filing Icon  
9/1/2021Kevin M. LalandeDirectorBuy4,589$10.87$49,882.43View SEC Filing Icon  
8/30/2021Kevin M. LalandeDirectorBuy8,625$10.52$90,735.00View SEC Filing Icon  
8/27/2021Kevin M. LalandeDirectorBuy4,981$10.50$52,300.50View SEC Filing Icon  
8/25/2021Kevin M. LalandeDirectorBuy14,900$9.87$147,063.00View SEC Filing Icon  
8/23/2021Kevin M. LalandeDirectorBuy37,800$9.58$362,124.00View SEC Filing Icon  
8/20/2021Kevin M. LalandeDirectorBuy35,679$8.73$311,477.67View SEC Filing Icon  
8/18/2021Kevin M. LalandeDirectorBuy28,870$8.73$252,035.10View SEC Filing Icon  
8/16/2021Kevin M. LalandeDirectorBuy31,000$7.96$246,760.00View SEC Filing Icon  
8/12/2021Kevin M. LalandeDirectorBuy31,000$7.55$234,050.00View SEC Filing Icon  
1/8/2021James E FlynnMajor ShareholderSell106,512$22.31$2,376,282.72View SEC Filing Icon  
1/6/2021James E FlynnMajor ShareholderSell29,039$22.48$652,796.72View SEC Filing Icon  
See Full Table
Nevada Desert more Valuable than Wall Street or Silicon Valley?
It could be true, according to Nevada Governor Steve Sisolak. The state's desert flats contain more lithium than any other geography in the world. And with electric vehicles driving a global boom in demand for lithium-ion batteries, Nevada should be on every investor's radar.
Find Out How to Take Advantage of Nevada's Lithium

SEC Filings (Institutional Ownership Changes) for Lumos Pharma (NASDAQ:LUMO)

38.35% of Lumos Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LUMO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Lumos Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Renaissance Technologies LLC271,712$2.55M0.0%-1.9%3.251%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.59,460$0.56M0.0%-3.3%0.711%Search for SEC Filing on Google Icon
5/12/2022Private Advisor Group LLC28,013$0.26M0.0%N/A0.335%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN315,973$2.19M0.0%-0.4%3.781%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.355,990$2.47M0.0%N/A4.260%Search for SEC Filing on Google Icon
2/15/2022Lion Point Capital LP51,205$0.35M0.1%-87.4%0.613%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.355,990$2.47M0.0%N/A4.260%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC277,112$1.92M0.0%-3.2%3.316%Search for SEC Filing on Google Icon
2/4/2022Envestnet Asset Management Inc.10,368$72K0.0%N/A0.124%Search for SEC Filing on Google Icon
2/2/2022PVG Asset Management Corp10,175$71K0.3%N/A0.122%Search for SEC Filing on Google Icon
1/14/2022Investors Financial Group LLC30,600$0.21M0.1%-11.6%0.366%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp11,857$0.11M0.0%-25.7%0.142%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC15,348$0.15M0.0%N/A0.184%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC11,869$0.11M0.0%N/A0.142%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP20,953$0.20M0.0%-46.8%0.251%Search for SEC Filing on Google Icon
11/15/2021Minerva Advisors LLC34,015$0.32M0.2%N/A0.407%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC286,412$2.72M0.0%-6.3%3.427%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC28,356$0.27M0.0%+22.3%0.339%Search for SEC Filing on Google Icon
11/12/2021Connor Clark & Lunn Investment Management Ltd.33,427$0.32M0.0%+4.7%0.400%Search for SEC Filing on Google Icon
10/21/2021Investors Financial Group LLC34,600$0.33M0.2%+16.9%0.414%Search for SEC Filing on Google Icon
10/12/2021Marquette Asset Management LLC13,234$0.13M0.0%+48.4%0.158%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN215,958$2.16M0.0%+30.0%2.584%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD159,595$1.59M0.0%N/A1.910%Search for SEC Filing on Google Icon
8/16/2021Opaleye Management Inc.382,000$3.82M0.6%+1.4%4.571%Search for SEC Filing on Google Icon
8/16/2021State Street Corp11,237$0.11M0.0%N/A0.134%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC305,757$3.06M0.0%-8.0%3.659%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP39,405$0.39M0.0%-5.0%0.472%Search for SEC Filing on Google Icon
8/12/2021Connor Clark & Lunn Investment Management Ltd.31,938$0.32M0.0%-4.1%0.382%Search for SEC Filing on Google Icon
7/19/2021Marquette Asset Management LLC8,919$89K0.0%N/A0.107%Search for SEC Filing on Google Icon
5/18/2021Opaleye Management Inc.376,900$4.41M0.6%+34.0%4.516%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C373,117$4.37M0.1%-60.1%4.471%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP41,459$0.49M0.0%-4.8%0.497%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC332,419$3.89M0.0%+7.6%3.983%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp2,960$35K0.0%-75.5%0.035%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC5,879$69K0.0%+65.0%0.070%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.71,078$0.83M0.0%+2.9%0.853%Search for SEC Filing on Google Icon
4/14/2021Investors Financial Group LLC29,200$0.34M0.2%+60.4%0.350%Search for SEC Filing on Google Icon
2/22/2021West Financial Advisors LLC784$28K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2021Verition Fund Management LLC9,835$0.35M0.0%N/A0.119%Search for SEC Filing on Google Icon
2/16/2021One68 Global Capital LLC5,855$0.21M0.4%N/A0.071%Search for SEC Filing on Google Icon
2/16/2021ExodusPoint Capital Management LP37,203$1.33M0.0%N/A0.448%Search for SEC Filing on Google Icon
2/12/2021Opaleye Management Inc.281,287$10.05M1.3%+16.8%3.390%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp12,081$0.43M0.0%+292.0%0.146%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC308,812$11.03M0.0%+0.9%3.722%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN117,660$4.20M0.0%+1.1%1.418%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp17,493$0.63M0.0%N/A0.211%Search for SEC Filing on Google Icon
1/21/2021Foster Group Inc.7,283$0.22M0.0%N/A0.088%Search for SEC Filing on Google Icon
1/19/2021Investors Financial Group LLC18,200$0.65M0.4%-16.4%0.219%Search for SEC Filing on Google Icon
11/12/2020Connor Clark & Lunn Investment Management Ltd.31,978$0.44M0.0%-12.5%0.386%Search for SEC Filing on Google Icon
11/10/2020Texas Yale Capital Corp.16,000$0.22M0.0%+6.7%0.193%Search for SEC Filing on Google Icon
11/9/2020Acadian Asset Management LLC5,161$71K0.0%-85.7%0.062%Search for SEC Filing on Google Icon
11/5/2020Wells Fargo & Company MN116,392$1.61M0.0%+3.7%1.403%Search for SEC Filing on Google Icon
10/14/2020Investors Financial Group LLC21,766$0.30M0.2%-81.1%0.262%Search for SEC Filing on Google Icon
9/15/2020Two Sigma Advisers LP13,298$0.22M0.0%-5.0%0.160%Search for SEC Filing on Google Icon
8/14/2020Logos Global Management LP50,000$0.83M0.2%N/A0.606%Search for SEC Filing on Google Icon
8/14/2020Jefferies Group LLC120,651$1.99M0.0%+13.0%1.462%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Lumos Pharma logo
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.
Read More on Lumos Pharma

Today's Range

Now: $7.69
Low: $7.50
High: $8.27

50 Day Range

MA: $8.89
Low: $7.43
High: $10.04

52 Week Range

Now: $7.69
Low: $6.15
High: $12.05

Volume

1,023 shs

Average Volume

14,751 shs

Market Capitalization

$64.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Lumos Pharma?

Lumos Pharma's top insider shareholders include:
  1. John C Mckew (Insider)
  2. James E Flynn (Major Shareholder)
  3. Kevin M Lalande (Director)
Learn More about top insider investors at Lumos Pharma.

Who are the major institutional investors of Lumos Pharma?

Lumos Pharma's top institutional shareholders include:
  1. Renaissance Technologies LLC — 3.25%
  2. BlackRock Inc. — 0.71%
  3. Private Advisor Group LLC — 0.34%
  4. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Lumos Pharma stock.

Which major investors are selling Lumos Pharma stock?

In the last quarter, LUMO stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. BlackRock Inc.

Which major investors are buying Lumos Pharma stock?

In the previous quarter, LUMO stock was purchased by institutional investors including:
  1. Private Advisor Group LLC
"new normal coming"???
PhD who walked away from her million-dollar career at Goldman Sachs says "Strange new normal coming"
Learn more.